Navigation Links
Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast Cancer Inquiry
Date:12/20/2009

. Allen M. Gown, an internationally recognized expert in the technique of IHC, and the laboratory has become a highly respected national reference laboratory for the performance of IHC and other specialized pathology testing of breast and other tumors. The laboratory was involved in a landmark study published in December 2006 demonstrating that reagents employed for the identification of ER in breast cancer specimens at PhenoPath Laboratories were significantly more sensitive and specific than those widely used in the United States and around the world. PhenoPath’s vast experience and expertise with IHC in this context was a major factor in the selection of this laboratory by the Province of Quebec for this retesting.

In the re-analysis, results of which were just announced, a total of 87 women were found to have received a false negative result from the original pathology laboratory tests in Quebec. Of this number, 39 were required to alter their treatment and among them five women died. Minister of Health Yves Bolduc said it was impossible to determine whether the women died as a result of being improperly treated.

Despite the relatively low rate of “false negative” ER tests revealed by the PhenoPath Laboratories retesting of the original Quebec laboratory results, given the absence of standardization and comparable retesting studies in the United States, and the additional potential sources of error not addressed in this retesting, the error rate in ER testing in breast cancer in laboratories the United States remains uncertain.

About PhenoPath Laboratories:
PhenoPath Laboratories is a national anatomic pathology reference laboratory located in Seattle, Washington. PhenoPath provides consultation services and diagnostic and research applications of immunohistochemistry (IHC), flow cytometry, FISH, CISH and PCR testing to pathologists and clinical laboratories across the United States and the world.


'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc.
2. Seattle-Based Marsha Rivkin Center for Ovarian Cancer Research Appoints Nancy Sclater, Executive Director
3. Seattle-Based Law Firm Williams Kastner Receives Significant Defense Verdict in Trade Secret Business Litigation Case
4. Upscale Seattle-Based Skincare Clinic Expands Into California With Unique Custom Tailored Skincare Approach
5. BioMosaics Glypican-3 Antibody (clone 1G12) Validated at PhenoPath Laboratories for Immunohistochemical Detection of Liver Cancer
6. Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine Tablets
7. Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health
8. Reportlinker Adds Whos Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report
9. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
10. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
11. ARUP Laboratories Scientist Tanya Sandrock Receives NIH Grant to Search for Additional HIV Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up with ... top skin care manufacturer EMINENCE to meet customer demands. ... and active organic ingredients to promote actual change rather ... products offer. For this reason it’s not hard to ... like products that do what they say they will ...
(Date:6/19/2013)... 2013 Strict rules for ... Orriant is launching a new tool to help ... with regulations. New HHS regulations will soon ... if their employer offers outcome-based, health-contingent, compliant wellness ... with these standards for nearly a decade. Orriant ...
(Date:6/19/2013)... New York, New York (PRWEB) June 19, 2013 ... involving pancreatitis and pancreatic cancer continue to mount in ... the U.S. Food & Drug Administration (FDA) recently held ... other diabetes drugs known as incretin mimetics. According ... may seek additional data from the makers of Januvia ...
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... disparities between minority and white clients in success ... these disparities vary widely from state to state. ... states there,s something amiss," says Stephan Arndt, Ph.D., ... strong racial and ethnic disparities for people in ... successfully, and those disparities are something we need ...
Breaking Medicine News(10 mins):Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... , TUESDAY, Dec. 14 (HealthDay News) -- ... genetic mutations associated with adrenal gland tumors by identifying ... affect the adrenal gland, which is located above the ... can also be cancerous -- cause the adrenal gland ...
... R.I. [Brown University] Brown University sociologists have ... about risky sexual behavior among Ethiopian teenagers and ... Simple, portable, low-cost, and low-tech, the group,s new ... and confidentially during face-to-face interviews. Professors of sociology ...
... Dec. 14 (HealthDay News) -- Two reports from the U.S. ... is hitting young and older Americans across the economic,spectrum. ... and Prevention, released the reports on Tuesday. Looking at ... data from 1988 to 1994 and from 2005 to 2008, ...
... Dec. 14, 2010 Cancer Research Institute, Inc. (CRI), ... the science of tumor immunology and foster the discovery ... the Cancer Vaccine Acceleration Fund (CVAF), a new model ... with the Ludwig Institute for Cancer Research Ltd (LICR) ...
... French . , MONTREAL, December 14, 2010 The ... learn to recognize the sound of their parents, voice and the ... parents and newborns admitted to the intensive care unit can be ... , Jan Lariviere, a nurse in the neonatal clinic and the ...
... Gardner HealthDay Reporter , TUESDAY, Dec. 14 (HealthDay ... the most from health-care reform, a new report shows. ... the elimination of restrictions on people with preexisting conditions, while ... subsidized coverage through health insurance exchanges -- are slated for ...
Cached Medicine News:Health News:New survey device gets better information on teenage sexual behavior 2Health News:New survey device gets better information on teenage sexual behavior 3Health News:Obesity Rising Across All Income Levels: CDC 2Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 2Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 3Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 4Health News:Once upon a time in the Intensive Care Unit ... 2Health News:Report Finds Baby Boomers to Gain Most From Health Care Reform 2Health News:Report Finds Baby Boomers to Gain Most From Health Care Reform 3
(Date:6/19/2013)... 2013 The American Association for Homecare (AAHomecare), along ... , announced today the filing of a lawsuit ... , asking that the scheduled July 1 expansion of ... (DME) be stopped because of serious licensing irregularities. ... (HHS) Secretary Kathleen Sebelius as the defendant. ...
(Date:6/19/2013)... 19, 2013 Amgen is pleased to announce the ... , Canada and Puerto ... Amgen Award for Science Teaching Excellence (AASTE). Now in its ... through 12th grade level who have an outstanding ability to ... With a long-standing commitment to science education, Amgen established the ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in ... lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe ... even in patients who were at high-risk due to ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6
... Texas and KOLN, Germany, June 8, 2011 Luminex ... der Stadt Koln, Institute of Pathology and Institute for ... Pathogen Panel (GPP) is being used successfully as a ... suspected of having an E. coli infection.  This includes ...
... Company (NYSE: LLY ) today announced that ... California ruled in Lilly,s favor, vacating a temporary restraining ... a preliminary injunction that sought to impose restrictions on ... recently filed litigation involving the two companies, diabetes collaboration ...
Cached Medicine Technology:Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 2Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 3Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 4U.S. District Court Rules in Favor of Lilly in Amylin Litigation 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: